The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...
Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback